Neurology Department, Sainte-Anne Hospital, Paris, France.
Université Paris Descartes, Paris, France.
J Neurointerv Surg. 2019 Jun;11(6):535-538. doi: 10.1136/neurintsurg-2018-014568.
Mechanical thrombectomy (MT) has become the cornerstone of acute ischemic stroke management in patients with large vessel occlusion (LVO). The aim of this guideline document is to assist physicians in their clinical decisions with regard to MT.
These guidelines were developed based on the standard operating procedure of the European Stroke Organisation, and followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. An interdisciplinary working group identified 15 relevant questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence based recommendations. Expert opinion was provided if not enough evidence was available to provide recommendations based on the GRADE approach.
We found high quality evidence to recommend MT plus best medical management (BMM, including intravenous thrombolysis whenever indicated) to improve functional outcome in patients with LVO related acute ischemic stroke within 6 hours after symptom onset. We found moderate quality of evidence to recommend MT plus BMM in the 6-24 hour time window in patients meeting the eligibility criteria of published randomized trials. These guidelines further detail aspects of prehospital management, patient selection based on clinical and imaging characteristics, and treatment modalities.
MT is the standard of care in patients with LVO related acute stroke. Appropriate patient selection and timely reperfusion are crucial. Further randomized trials are needed to inform clinical decision making with regard to the mothership and drip-and-ship approaches, anesthaesia modalities during MT, and to determine whether MT is beneficial in patients with low stroke severity or large infarct volume.
机械取栓(MT)已成为伴有大血管闭塞(LVO)的急性缺血性脑卒中患者治疗的基石。本指南旨在协助临床医生在 MT 相关临床决策方面提供参考。
本指南是根据欧洲卒中组织的标准操作程序制定的,并遵循推荐分级的评估、制定与评价(GRADE)方法。一个跨学科工作组确定了 15 个相关问题,对文献进行了系统评价和荟萃分析,评估了现有证据的质量,并根据循证医学建议撰写了相关内容。如果基于 GRADE 方法提供建议的证据不足,则提供专家意见。
我们发现高质量证据支持在症状发作后 6 小时内,MT 联合最佳药物治疗(包括在有指征时静脉溶栓)可改善 LVO 相关急性缺血性脑卒中患者的功能结局。我们发现在符合已发表随机试验入组标准的 6-24 小时时间窗内,MT 联合最佳药物治疗具有中等质量证据支持。本指南进一步详细说明了院前管理、基于临床和影像学特征的患者选择以及治疗方式等方面的内容。
MT 是伴有 LVO 的急性脑卒中患者的标准治疗方法。适当的患者选择和及时再灌注至关重要。需要进一步的随机试验来为母船和滴注-转运方法、MT 期间的麻醉方式以及 MT 是否对低卒中严重程度或大梗死体积患者有益等方面提供循证医学决策依据。